Myogenic progenitor cells derived from human induced pluripotent stem cell are immune‐tolerated in humanized mice
Abstract It is still unclear if immune responses will compromise the large‐scale utilization of human induced pluripotent stem cells (hiPSCs)‐derived cell therapies. To answer this question, we used humanized mouse models generated by the adoptive transfer of peripheral blood mononuclear cells or th...
Main Authors: | Basma Benabdallah, Cynthia Désaulniers‐Langevin, Marie‐Lyn Goyer, Chloé Colas, Chantale Maltais, Yuanyi Li, Jean V. Guimond, Jacques P. Tremblay, Elie Haddad, Christian Beauséjour |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2021-02-01
|
Series: | Stem Cells Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/sctm.19-0452 |
Similar Items
-
Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
by: Basma Benabdallah, et al.
Published: (2019-11-01) -
Graphene Oxide Scaffold Stimulates Differentiation and Proangiogenic Activities of Myogenic Progenitor Cells
by: Mateusz Wierzbicki, et al.
Published: (2020-06-01) -
Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
by: Ruojie He, et al.
Published: (2020-05-01) -
Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusion
by: Franka Messner, et al.
Published: (2021-02-01) -
Metabolic Changes during In Vivo Maturation of PSC-Derived Skeletal Myogenic Progenitors
by: Phablo Abreu, et al.
Published: (2023-12-01)